IGF1 and Alzheimer disease: Thus, deletion or knock-down of IGF-IR or intracellular mediators of IGF signaling in various mouse models of AD resulted in a significant attenuation of pathological β-amyloid, neuro-inflammation, neuro-degeneration, and subsequent behavior changes (94‐98).